Welcome to LookChem.com Sign In|Join Free
  • or


Post Buying Request

224785-91-5 Suppliers

Recommended suppliersmore

Product FOB Price Min.Order Supply Ability Supplier
Vardenafil hydrochloride/Vardenafil HCl powder 224785-91-5 API pharmaceutical factory
Cas No: 224785-91-5
USD $ 1.0-3.0 / Kilogram 25 Kilogram 1 Metric Ton/Month Hubei DiBo chemical co., LTD Contact Supplier
Vardenafil hydrochloride/Vardenafil HCl powder cas 224785-91-5 Pharmaceutical API
Cas No: 224785-91-5
No Data 10 Gram 10 Kilogram/Month Wuhan Wonda Pharm Limited Contact Supplier
high purity Vardenafil EP8.0 factory
Cas No: 224785-91-5
No Data 1 Kilogram 200 Kilogram/Month Hangzhou Think Chemical Co. Ltd Contact Supplier
China Manufacturer Supply V-Ardenafil Hydrochloride CAS 224785-91-5 99%
Cas No: 224785-91-5
USD $ 10.0-20.0 / Gram 1 Gram 200 tons Metric Ton/Week Hebei Nengqian Chemical Import and Export Co. LTD Contact Supplier
Vardenafil CAS 224785-91-5
Cas No: 224785-91-5
No Data 10 Gram 5000 Kilogram/Month Shanghai PengMo Biotechnology Co.,Ltd Contact Supplier
Factory bulk supply Vardenafil powder purity 99% for men sexual enhancement
Cas No: 224785-91-5
USD $ 950.0-1000.0 / Kilogram 1 Kilogram 100 Metric Ton/Year Hubei Vanz Pharm Co.,Ltd Contact Supplier
Vardenafil HCL
Cas No: 224785-91-5
No Data 1 Kilogram 1 Metric Ton/Day Shandong Hanjiang Chemical Co., Ltd. Contact Supplier
Vardenafil premium manufacturer
Cas No: 224785-91-5
No Data 1 Kilogram 3 Metric Ton/Day Qingdao Beluga Import and Export Co., LTD Contact Supplier
Vardenafil hcl trihydrate 99% BP USP (ED) treatment Ready stock 224785-90-4 cas 224785-91-5
Cas No: 224785-91-5
No Data 1 Kilogram 1 Metric Ton/Day Hangzhou Fonlynn Health Technology Co., Ltd. Contact Supplier
Vardenafil hydrochloride,224785-91-5
Cas No: 224785-91-5
No Data No Data 1 Metric Ton/Day Wuhan MoonZY Biological Technology Co.,Ltd Contact Supplier

224785-91-5 Usage


A selective phsphodiesterase type 5 (PDE5) inhibitor

Chemical Synthesis

The synthesis started with 2- hydroxybenzonitrile. 2-Hydroxybenzonitrile (181) was alkylated with ethyl bromide to give 2-ethoxybenzonitrile in 97% yield as a liquid which was subsequently treated with AlMeClNH2, prepared from AlMe3 and NH4Cl, to give corresponding 2-ethoxybenzamidine (182) in 76% yield as a solid. Compound 182 was treated with hydrazine hydrate in ethanol to give hydrazide 183, which was used in the next step without isolation. Dakin-West reaction of 2- butyrylaminopropionic acid (184) with ethyl oxalyl chloride (185) in the presence of DMAP in refluxing pyridine/THF to give corresponding α-oxoamino-acid ester 186 which was also used for next step without isolation. Hydrazide 183 was condensed with ester 186 in refluxing ethanol to give triazinone 187 intermediate which was then cyclized to the final core structure, imidazo[5,1-f]triazin-4-one, using POCl3 to give 188 in 28% yield from 183. Compound 188 was sulfonylated with chlorosulfonic acid to give sulfonyl chloride 189 in 91% yield. Finally, 189 was condensed with N-ethylpiperazine (190) in dichloromethane to give vardenafil (XXIII) in 66% yield.

Chemical Properties

White to Off-White Cyrstalline Solid


Vardenafil was the second agent to be marketed and had the advantage that its onset time was not reduced by taking the medication on a full stomach . It is 30 times more potent as an inhibitor of PDE5 (mean IC50, 3.9 nM) than sildenafil and 10 times more potent than tadalafil, with a greater selectivity (>1,000 times) for human PDE5 than for human PDE2, PDE3, and PDE4 and moderate selectivity (>80 times) for PDE1. The PDE inhibitory selectivity and both the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Vardenafil specifically inhibited the hydrolysis of cGMP by PDE5, with an IC50 of 0.7 nM (sildenafil 6.6 nM). The IC50 of vardenafil for PDE1 was 180 nM, for PDE6 11 nM, and for PDE2, PDE3 and PDE4 more than 1,000 nM.

Enzyme inhibitor

Vardenafil also is rapidly absorbed and peaks in concentration (9.05 μg/mL after a 10-mg dose) after 0.9 hours, displaying a half-life of 4 to 5 hours. The absorption rate of both sildenafil and vardenafil are reduced when taken with a high-fat diet. The drug also is metabolized by hepatic CYP3A4, and a potential for drug–drug interaction with inhibitors or enhancers of CYP3A4 exists. Biochemical studies demonstrate a significant increase in selectivity of vardenafil over sildenafil for PDE5 versus PDE6. Whether this translates into a significant improvement in side effects must await studies in a greater population of patients.

General Description

Vardenafil, 4-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-9-methyl-7-propyl-3,5,6,8-tetrazabicyclo[4.3.0]nona-3,7,9-trien-2-one(Levitra), was the second PDE5 introduced in the U.S. market.The metabolism of vardenafil is primarily by CYP3A4.As such, concomitant use of CYP3A4 inhibitors such as ritonavir,indinavir, ketoconazole, as well as moderate CYP3Ainhibitors such as erythromycin typically results in significantincreases of plasma levels of vardenafil.


A phsphodiesterase 5 inhibitor.



According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017


1.1 GHS Product identifier

Product name Vardenafil hydrochloride

1.2 Other means of identification

Product number -
Other names VARDENAFIL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:224785-91-5 SDS

Please post your buying leads,so that our qualified suppliers will soon contact you!

*Required Fields